| Term | Count | % | | DRUG INEFFECTIVE | 4086 | 9.04% |
| TREATMENT FAILURE | 3077 | 6.81% |
| OCULAR HYPERAEMIA | 2345 | 5.19% |
| EYE IRRITATION | 1851 | 4.10% |
| MADAROSIS | 1388 | 3.07% |
| EYE PRURITUS | 1328 | 2.94% |
| ERYTHEMA OF EYELID | 1013 | 2.24% |
| EYE PAIN | 943 | 2.09% |
| HYPERSENSITIVITY | 853 | 1.89% |
| VISION BLURRED | 838 | 1.85% |
| INTRAOCULAR PRESSURE INCREASED | 720 | 1.59% |
| OFF LABEL USE | 718 | 1.59% |
| FATIGUE | 710 | 1.57% |
| HEADACHE | 677 | 1.50% |
| DRY EYE | 652 | 1.44% |
| EYE SWELLING | 649 | 1.44% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 584 | 1.29% |
| DYSPNOEA | 549 | 1.22% |
| INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION | 539 | 1.19% |
| EYELIDS PRURITUS | 530 | 1.17% |
| DIZZINESS | 522 | 1.16% |
| ERYTHEMA | 513 | 1.14% |
| NAUSEA | 511 | 1.13% |
| DIARRHOEA | 502 | 1.11% |
| INCORRECT DOSE ADMINISTERED | 495 | 1.10% |
| SKIN HYPERPIGMENTATION | 481 | 1.06% |
| FALL | 472 | 1.04% |
| VISUAL IMPAIRMENT | 463 | 1.02% |
| ASTHENIA | 447 | 0.99% |
| PRURITUS | 425 | 0.94% |
| EYELID OEDEMA | 419 | 0.93% |
| WRONG TECHNIQUE IN DRUG USAGE PROCESS | 404 | 0.89% |
| PAIN | 400 | 0.89% |
| DEATH | 384 | 0.85% |
| LACRIMATION INCREASED | 376 | 0.83% |
| EYELID IRRITATION | 375 | 0.83% |
| PRODUCT DOSE OMISSION ISSUE | 370 | 0.82% |
| RASH | 358 | 0.79% |
| CATARACT | 345 | 0.76% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 332 | 0.73% |
| GLAUCOMA | 329 | 0.73% |
| MALAISE | 324 | 0.72% |
| EYE DISCHARGE | 305 | 0.68% |
| THERAPEUTIC RESPONSE DECREASED | 300 | 0.66% |
| GROWTH OF EYELASHES | 295 | 0.65% |
| SKIN DISCOLOURATION | 292 | 0.65% |
| PNEUMONIA | 289 | 0.64% |
| VISUAL ACUITY REDUCED | 286 | 0.63% |
| TRICHORRHEXIS | 281 | 0.62% |
| BLEPHARAL PIGMENTATION | 279 | 0.62% |
| ARTHRALGIA | 278 | 0.62% |
| VOMITING | 277 | 0.61% |
| DRUG DOSE OMISSION | 272 | 0.60% |
| PAIN IN EXTREMITY | 267 | 0.59% |
| DRUG HYPERSENSITIVITY | 266 | 0.59% |
| COUGH | 265 | 0.59% |
| WEIGHT DECREASED | 264 | 0.58% |
| ACCIDENTAL EXPOSURE TO PRODUCT | 251 | 0.56% |
| INSOMNIA | 248 | 0.55% |
| PRODUCT QUALITY ISSUE | 241 | 0.53% |
| HYPERTENSION | 238 | 0.53% |
| EYE DISORDER | 224 | 0.50% |
| FOREIGN BODY SENSATION IN EYES | 214 | 0.47% |
| DECREASED APPETITE | 206 | 0.46% |
| BLOOD PRESSURE INCREASED | 204 | 0.45% |
| CONSTIPATION | 202 | 0.45% |
| PRODUCT PACKAGING QUANTITY ISSUE | 200 | 0.44% |
| OCULAR DISCOMFORT | 197 | 0.44% |
| BACK PAIN | 195 | 0.43% |
| GAIT DISTURBANCE | 191 | 0.42% |
| ANAEMIA | 189 | 0.42% |
| ANXIETY | 189 | 0.42% |
| HAIR GROWTH ABNORMAL | 188 | 0.42% |
| HYPOTENSION | 187 | 0.41% |
| CONDITION AGGRAVATED | 185 | 0.41% |
| URINARY TRACT INFECTION | 180 | 0.40% |
| PYREXIA | 178 | 0.39% |
| NO ADVERSE EVENT | 176 | 0.39% |
| PHOTOPHOBIA | 174 | 0.39% |
| FEELING ABNORMAL | 172 | 0.38% |
| BLINDNESS | 168 | 0.37% |
| CONFUSIONAL STATE | 160 | 0.35% |
| DEPRESSION | 159 | 0.35% |
| PERIPHERAL SWELLING | 159 | 0.35% |
| SWELLING OF EYELID | 158 | 0.35% |
| MYALGIA | 156 | 0.35% |
| SOMNOLENCE | 156 | 0.35% |
| ABDOMINAL DISCOMFORT | 153 | 0.34% |
| EXPIRED PRODUCT ADMINISTERED | 153 | 0.34% |
| ATRIAL FIBRILLATION | 151 | 0.33% |
| CHEST PAIN | 151 | 0.33% |
| NASOPHARYNGITIS | 149 | 0.33% |
| CEREBROVASCULAR ACCIDENT | 148 | 0.33% |
| DRUG ADMINISTERED AT INAPPROPRIATE SITE | 148 | 0.33% |
| EYELID PAIN | 148 | 0.33% |
| OEDEMA PERIPHERAL | 147 | 0.33% |
| BLOOD GLUCOSE INCREASED | 145 | 0.32% |
| WEIGHT INCREASED | 145 | 0.32% |
| ALOPECIA | 144 | 0.32% |
| BURNING SENSATION | 142 | 0.31% |
| Total | 45182 | |